2399 related articles for article (PubMed ID: 16856117)
1. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.
Pai NP; Lawrence J; Reingold AL; Tulsky JP
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006148. PubMed ID: 16856117
[TBL] [Abstract][Full Text] [Related]
2. Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.
Pai NP; Tulsky JP; Lawrence J; Colford JM; Reingold AL
Cochrane Database Syst Rev; 2005 Oct; (4):CD005482. PubMed ID: 16235406
[TBL] [Abstract][Full Text] [Related]
3. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
5. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
[TBL] [Abstract][Full Text] [Related]
6. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
7. Interventions to improve adherence to antiretroviral therapy in children with HIV infection.
Bain-Brickley D; Butler LM; Kennedy GE; Rutherford GW
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009513. PubMed ID: 22161452
[TBL] [Abstract][Full Text] [Related]
8. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Sangani P; Rutherford G; Wilkinson D
Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
[TBL] [Abstract][Full Text] [Related]
9. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
Siegfried N; Uthman OA; Rutherford GW
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
[TBL] [Abstract][Full Text] [Related]
11. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Wilkinson D; Rutherford G
Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
[TBL] [Abstract][Full Text] [Related]
12. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Ng BE; Butler LM; Horvath T; Rutherford GW
Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
[TBL] [Abstract][Full Text] [Related]
13. Antihelminthics in helminth-endemic areas: effects on HIV disease progression.
Means AR; Burns P; Sinclair D; Walson JL
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006419. PubMed ID: 27075622
[TBL] [Abstract][Full Text] [Related]
14. Structured treatment interruption in patients infected with HIV: a new approach to therapy.
Gulick RM
Drugs; 2002; 62(2):245-53. PubMed ID: 11817971
[TBL] [Abstract][Full Text] [Related]
15. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
[TBL] [Abstract][Full Text] [Related]
16. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
Siegfried N; Davies MA; Penazzato M; Muhe LM; Egger M
Cochrane Database Syst Rev; 2013 Oct; 10(10):CD010309. PubMed ID: 24114324
[TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
18. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
